"Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis."

Published by: GIR (GlobalInfoResearch)
Catalog: Pharm & Healthcare
Publishing Date: Dec 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 110
Tables and Figures: 137

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=2662[url]

Scope of the Report:

This report focuses on the Human Milk Oligosaccharides (HMO) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Inbiose
Elicityl SA
Jennewein Biotechnologie
Glycom
ZuChem
Dextra Laboratories

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
Neutral
Acidic
Other

Market Segment by Applications, can be divided into
Infant formula
Functional food & beverages
Food supplements
Others

There are 13 Chapters to deeply display the global Human Milk Oligosaccharides (HMO) market.

Chapter 1, to describe Human Milk Oligosaccharides (HMO) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Milk Oligosaccharides (HMO), with sales, revenue, and price of Human Milk Oligosaccharides (HMO), in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Milk Oligosaccharides (HMO), for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, traders, dealers, appendix and data source.

Betty
Sales Director
E-mail：[email protected]
Tel: HK:00852-58197708 USA:0013479661888
Add: Room 1902 Two International Finance Centre 8 Finance Street, Central Hong Kong
Website: http://www.globalinforesearch.com/goods_all.php